Single-use systems have greatly improved and simplified common manufacturing issues.
James M. Robinson
Advertisement
James M. Robinson is vice-president of technical and quality operations at Novavax, Inc.
Articles by James M. Robinson
With virus-based production, vaccines can be available in 10-12 weeks.
Advertisement
Latest Updated Articles
Tanks for the MemoriesPublished: March 1st 2009 | Updated:
An Alternative to the Scale-up and Distribution of Pandemic Influenza VaccinePublished: January 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
